Next Article in Journal
The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status
Previous Article in Journal
In Pursuit of Novel Markers: Unraveling the Potential of miR-106, CEA and CA 19-9 in Gastric Adenocarcinoma Diagnosis and Staging
Previous Article in Special Issue
Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Expanding the Phenotypic Spectrum of Pathogenic KIAA0586 Variants: From Joubert Syndrome to Hydrolethalus Syndrome

by
Desirée Deconte
1,
Bruna Lixinski Diniz
1,
Jéssica K. Hartmann
2,
Mateus A. de Souza
2,
Laira F. F. Zottis
2,
Paulo Ricardo Gazzola Zen
3,
Rafael F. M. Rosa
3 and
Marilu Fiegenbaum
4,*
1
Programa de Pós-Graduação em Patologia, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre 90050-170, Brazil
2
Faculty of Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre 90050-170, Brazil
3
Departamento de Clínica Médica, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre 90050-170, Brazil
4
Departamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre 90050-170, Brazil
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(14), 7900; https://doi.org/10.3390/ijms25147900
Submission received: 26 April 2024 / Revised: 8 July 2024 / Accepted: 15 July 2024 / Published: 19 July 2024

Abstract

:
KIAA0586 variants have been associated with a wide range of ciliopathies, mainly Joubert syndrome (JS, OMIM #616490) and short-rib thoracic dysplasia syndrome (SRTD, OMIM #616546). However, the hypothesis that this gene is involved with hydrolethalus syndrome (HSL, OMIM #614120) and orofaciodigital syndrome IV (OMIM #258860) has already been raised. Ciliopathies’ clinical features are often overlapped despite differing in phenotype severity. Besides KIAA0586, HYLS1 and KIF7 are also known for being causative of ciliopathies, indicating that all three genes may have similar or converging genomic pathways. Overall, the genotypic and phenotypic spectrum of ciliopathies becomes wider and conflicting while more and more new variants are added to this group of disorders’ molecular pot. In this case report we discuss the first Brazilian individual clinically diagnosed with hydrolethalus syndrome and molecular findings that demonstrate the role of KIAA0586 as a causative gene of a group of genetic disorders. Also, recent reports on individuals with intronic and exonic variants combined leading to ciliopathies support our patient’s molecular diagnosis. At the same time, we discuss variable expressivity and overlapping features in ciliopathies.

1. Introduction

The cilia are an essential component of signal transduction during embryonic development involved in cellular detection and the management of external signals. Dysfunctional cilia are often associated with ciliopathies, a heterogeneous group of genetic diseases that manifest during childhood and adolescence [1,2,3]. The majority of syndromes related to genes involved in ciliary function are monogenic and have an autosomal recessive trait. Although the phenotypic spectrum is known to be wide, the main clinical features observed in ciliopathies encompass retinal degeneration, renal disease, skeletal malformations, brain anomalies, and neurological impairment [1,2,3,4,5,6].
Genes related to ciliopathies are called ciliary genes, and over 800 genes have already been identified as involved in the ciliary–centrosome function [7]. Among the ciliary genes, KIAA0586 (OMIM #610178, 14q23.1), the human ortholog of mouse and chicken TALPID3, encodes a conserved centrosomal protein required for sonic hedgehog signaling (Shh), vertebrate development, and ciliogenesis [8,9,10]. Previous animal model studies showed that the KIAA0586 knockdown phenotype is associated with severe ciliogenesis impairment and Shh disruption [11,12]. Primary cilia have an essential role in sonic hedgehog signaling in mammals, and their function is essential for correct embryonic formation. As a result, variants in ciliary genes like KIAA0586 are associated with severe clinical consequences [11,12].
Pathogenic variants in KIAA0586 are often associated with a wide range of ciliopathies, such as Joubert syndrome (JS, OMIM #616490) and short-rib thoracic dysplasia syndrome (SRTD, OMIM #616546), and the hypothesis of this gene being involved with hydrolethalus syndrome (HSL, OMIM #614120) and orofaciodigital syndrome IV (OMIM #258860) has been raised in the literature [4,5,6,8,13]. Although the severity of ciliopathies may differ, a variety of clinical manifestations are frequently overlapped. Moreover, these diseases have molecular heterogeneity, with several genes being associated with one or more ciliopathies [4,14]. Therefore, the etiology of these syndromes as well as the role of the involved genes are yet to be elucidated to understand the genotype–phenotype correlation behind ciliopathies disorders [14].
Here we report on the first Brazilian individual clinically diagnosed with hydrolethalus syndrome and molecular findings that instigate the discussion on the role of KIAA0586 as a causative gene of ciliopathies. Also, we provided an overview of the wide phenotype range in the ciliopathies spectrum as well as the overlapping genes between them by gathering previous cases reported in the literature and proposing whether gene expression variability among ciliopathies is a possibility.

2. Results

2.1. Clinical Findings

The proband was the first child of young and non-consanguineous parents with no similar cases in the family, although the father’s sister was described as being born with clubfoot. Both parents have German ancestry. A previous history of pregnancy loss was denied.
The mother had two episodes of bleeding in the third month of pregnancy. She used piperidolate hydrochloride and progesterone but denied smoking or any drug use during gestation. In the second trimester, ultrasound and magnetic resonance imaging (MRI) identified Dandy–Walker malformation, corpus callosum agenesis, microphthalmia, reduced chest diameter, short limbs, increased amount of amniotic fluid (polyhydramnios), and a retrovesical cystic mass, which, postnatally, was found to be a didelphic uterus with hydrometrocolpos; the fetal echocardiography was normal. The parents chose not to perform fetal karyotyping by amniocentesis.
The proband, female, was born prematurely at 35 weeks and 2 days by cesarean section, weighing 2649 g (percentile 70) and measuring 46 cm (percentile 53), with a head circumference of 33 cm (percentile 83) and Apgar score of three at the first minute and five at the fifth minute. She presented respiratory distress and needed to be placed on mechanical ventilation. During the physical examination, a large anterior fontanelle, deep-set eyes with an impression of microphthalmia, low and broad nasal root, median cleft lip, cleft palate, micrognathia, hypoplastic and malformed tongue, dysplastic, small and low-set ears with a preauricular pit on the left, short neck with redundant skin, narrow thorax, postaxial polydactyly of hands, wrists arthrogryposis; camptodactyly of fingers, labia majora hypoplasia, anteriorly placed anus, and broad/bifid hallux (preaxial polydactyly) were noted. A brain ultrasound confirmed the findings observed during the prenatal period and identified the presence of dilated lateral ventricles. Abdominal/pelvic ultrasound showed pielocalicial and ureteral dilatation, as well as a didelphic uterus with hydrometrocolpos. The ophthalmologic assessment confirmed the apparent bilateral microphthalmia. A radiographic evaluation showed an elongated skull with a large posterior fossa, a small jaw, a narrow thorax with little expanded lungs and short ribs, wide iliac bones with a small sciatic notch, underdeveloped vertebrae, and humerus shortening. The child died within 25 days of life due to sudden respiratory dysfunction. A postnatal MRI could not be performed.

2.2. Genetic Analysis Results

Chromosomal microarray analysis revealed a deletion at chromosome 7q (71,869,384–76,820,289), a deletion at chromosome 14q (38,465,567–38,584,405), and two deletions at chromosome Xq (62,036,670–67,171,633; 71,632,324–78,216,024). Gene content for these deletions can be found in Supplementary Table S1. In addition, genes in the deleted regions were crossed with all ciliary genes described in the KEGG database to identify potential involvement in cilia function (Supplementary Table S2). At chromosome 7, two ciliary genes—CLDN3 and CLDN4—were found to be deleted; however, neither of them justifies the clinical features presented in our case. Moreover, none of the alterations identified by CMA were associated with the proband phenotype. A pathogenic variant in KIAA0586 was identified by NGS (NM_001244189.1:c.4018del, p.Glu1340ArgfsX10) in both the father’s and proband’s samples. This variant was not described in the literature. The mother sequence was normal. However, rtPCR analysis showed a probable intronic mutation at KIAA0586 in the mother’s sample, which led to an aberrant transcript. This result suggests that the second causative variant may be a mutation not identified by NGS inherited from the mother. Although CMA results showed a deletion on chromosome 14, the deleted region does not comprise the KIAA0586 nor any known gene (Supplementary Table S1).
Unfortunately, proband rtPCR could not be performed and the inheritance of the mother’s intronic variant was not confirmed. Hydrolethalus is an autosomal recessive syndrome, which implies that a variant in both alleles is to be expected to justify the lethal phenotype. Future research should consider intronic analysis before rejecting any autosomal recessive disease hypothesis or suspicion.

3. Discussion

Hydrolethalus syndrome (HLS) is a lethal genetic syndrome with an autosomal recessive trait characterized by the association of postaxial polydactyly and preaxial polydactyly of hands and feet, micrognathia, and hydrocephaly or anencephaly with a key-hole defect of the occipital bone [15]. Researchers have associated HYLS1 and KIF7 as key genes in this disorder [16,17]. The HYLS1 gene showed alternative splicing, where the transcript was found to be present in multiple tissues during fetal development [18]. Also, an experiment with mice harboring the HYLS1 variant showed that the animals die shortly after birth and exhibit developmental defects that resemble several manifestations of the human syndrome [19]. The KIF7 gene, on the other hand, encodes a cilia-associated protein that regulates the hedgehog signaling pathway. In vivo genetic interaction studies indicated that the knockdown of KIF7 could exacerbate the ciliopathy transcripts since KIF7 expression in cell lines causes defects in cilia formation and induces abnormal centrosome duplication [17,20]. However, the case reported in this paper differs from those already described, since the molecular finding on an HLS individual was on the KIAA0586 gene.
Although KIAA0586 is not the first candidate gene for HLS, it is associated with ciliopathies [6,8,21]. Ciliopathies have overlapping features, including renal and liver disorders, retinal degeneration, central nervous system defects, abnormal bone growth, and polydactyly [2,3]. Joubert syndrome was one of the first ciliopathy disorders recognized after the identification of the subcellular localizations and functions in the defective proteins [2,3,22]. JS phenotype is based on neurological features, abnormal eye movements, ataxia, cognitive impairment, and agenesis of the cerebellar vermis [23]. To date, several genes have been identified as causing the syndrome. However, many patients remain undiagnosed, suggesting that genetic heterogeneity may justify the reason why molecular diagnosis can be challenging [21]. Whole exome sequencing (WES) is preferable, owing to ciliopathies’ high diagnostic yield. In 2017, Vilboux et al. [24] suggested that if WES is not possible, then updated Joubert syndrome gene panels are preferable in most cases. In addition, in the absence of mainly phenotypic clues, prioritization of the most prevalent JS genes, including KIAA0586, may be reasonable. The mutation of known genes accounts for approximately half of the cases. Similar to our study, in 2015, Stephen et al. [25] identified a novel locus with a homozygous splice site mutation in KIAA0586, a known lethal ciliopathy locus in model organisms, in patients clinically diagnosed with JS. The truncating KIAA0586 mutations observed may result in loss of gene function and consequently abnormal tissue polarity, centrosome length and orientation, and centriolar satellites.
The phenotype of KIAA0586-affected subjects may range from a hydrolethalus phenotype to SRTDS. In 2015, Alby et al. [4] identified homozygous nonsense and splicing KIAA0586 mutations as responsible for lethal ciliopathies in patients with similar phenotypes to that of HLS. All the fetuses and individuals reported by the authors showed lethal phenotypes consistent with a defect in hedgehog signaling and were similar to the phenotype described in the animal models of KIAA0586. SRTD with or without polydactyly refers to a group of skeletal ciliopathies with an autosomal recessive trait that is characterized by a constricted thoracic cage, short ribs, shortened tubular bones, polydactyly, and a ‘trident’ appearance of the acetabular roof [26]. Some forms of SRTD are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life [27]. Looking at all clinical descriptions, our case showed features shared in all three syndromes (Figure 1).
Overlapping features in genetic syndromes are increasing as we deepen our research on molecular diagnosis. At the same time, the number of new genetic disorders is also rising since new technologies are available to map and explore known genes that cause specific clinical phenotypes [28]. Although clinical and molecular diagnosis is crucial to elucidating an individual rare condition, addressing a possible variable expressivity of phenotypes with too many different names can be confusing and hinder the process more than aid. There are several explanations for variable expressivity and clinical heterogeneity in genomic disorders: genetic locus, variant type, number of genes involved, multiple allelism, protein isoforms, and modifier genes are some of them. In addition, a new theory of “true oligogenic” was also raised to understand such complexity: authors have proposed that the actions of two or more recessive genes with heterozygous mutations may result in a phenotype only when the mutations coexist (which may be our index case) [3,28,29].
Our patient showed a paternal inherited variant on KIAA0586, however, after an exome panel investigation for ciliopathies, we did not succeed in completely unraveling the molecular disarray. As the majority of ciliopathies are autosomal recessive inheritance, a heterozygous mutation would not fulfill the requirements to express the syndrome. Curiously, the proband mother had an intronic truncated variant on the same gene that could provide the missing “other half”. Recent studies reported cases of individuals diagnosed with ciliopathies that have both a heterozygous variant on an exon and a heterozygous variant on an intron, which justified the phenotype [30,31,32]. In these cases, the intronic variants led to a cryptic exon that somehow disrupted the encoded protein. Therefore, since exonic and intronic variants can be causative of ciliopathies, we believe that despite the known exon inherited variant, the aberrant intronic variant may have been inherited from the mother, leading to the clinical hydrolethalus phenotype. The abnormal intronic region would, then, replace the expected second exonic mutation. Although the intronic variant hypothesis could be a plausible response, we cannot assess the proband molecular diagnosis. Furthermore, the involvement of other genes or variants cannot be discarded.

4. Materials and Methods

Molecular Analysis

High-resolution GTG banding karyotype analysis was performed from lymphocyte cell cultures (46, XX). DNA was isolated from peripheral blood lymphocytes using the Gentra Puregene Blood Kit (Qiagen, Valencia, CA, USA). The germline copy number variations (CNVs) were investigated using a high-density CytoScan HD Array platform (Affymetrix, Santa Clara, CA, USA) and the final data were analyzed by the Chromosome Analysis Suite software v.3.1 (Affymetrix, NetAffx Annotation Files version 33.1—hg19). A new generations sequencing (NGS) panel for ciliopathies (Cildag V1 panel) was performed in both the patient and parent’s samples using the SureSelect 174 genes kit (Agilent, Santa Clara, CA, USA) and the NextSeq500 sequencer (Illumina, San Diego, CA, USA). Gene coordinates cited throughout the manuscript were based on the genome build GRCh38/hg38.
The medical ethics committee of Universidade Federal de Ciências da Saúde de Porto Alegre and Hospital Santa Casa de Misericórdia de Porto Alegre approved the study (69178217.7.0000.5345). The study was conducted in accordance with the Helsinki declaration.

5. Conclusions

To sum up, as the number of ciliopathy-associated genes increases and the range of overlapping features between ciliopathies becomes more common, the need to better understand the genotype–phenotype correlation becomes clearer. In addition, elucidating the variable expressivity is essential to comprehending how many different syndromes we have. To achieve that, NGS panels may have to start including screening of intronic regions since the current scenario involves mostly molecular analysis focused on exploring exons. Overall, phenotype severity and molecular diagnosis should be investigated together to better propose a possible degree of ciliopathies disorders.

Supplementary Materials

The supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms25147900/s1.

Author Contributions

D.D. and B.L.D.: conceptualization, methodology, data analysis, writing—original draft, review, and editing. J.K.H., L.F.F.Z. and M.A.d.S.: writing and review. R.F.M.R. and P.R.G.Z.: conceptualization, methodology, writing—original draft, review. M.F.: conceptualization, methodology, data analysis, writing—original draft, review, and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (grant number 88887.481777/2020-00).

Institutional Review Board Statement

The medical ethics committee of Universidade Federal de Ciências da Saúde de Porto Alegre and Hospital Santa Casa de Misericórdia de Porto Alegre approved the study (69178217.7.0000.5345). The study was conducted in accordance with the Helsinki declaration.

Informed Consent Statement

Informed consent was obtained from the parents of the index patient.

Data Availability Statement

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Waters, A.M.; Beales, P.L. Ciliopathies: An expanding disease spectrum. Pediatr. Nephrol. 2011, 26, 1039–1056. [Google Scholar] [CrossRef] [PubMed]
  2. Braun, D.A.; Hildebrandt, F. Ciliopathies. Cold Spring Harb. Perspect. Biol. 2017, 9, a028191. [Google Scholar] [CrossRef] [PubMed]
  3. Hildebrandt, F.; Benzing, T.; Katsanis, N. Ciliopathies. N. Engl. J. Med. 2011, 364, 1533–1543. [Google Scholar] [CrossRef] [PubMed]
  4. Alby, C.; Piquand, K.; Huber, C.; Megarbane, A.; Ichkou, A.; Legendre, M.; Pelluard, F.; Encha-Ravazi, F.; Abi-Tayeh, G.; Bessieres, B.; et al. Mutations in KIAA0586 cause lethal ciliopathies ranging from a hydrolethalus phenotype to short-rib polydactyly syndrome. Am. J. Hum. Genet. 2015, 97, 311–318. [Google Scholar] [CrossRef] [PubMed]
  5. Malicdan, M.C.V.; Vilboux, T.; Stephen, J.; Maglic, D.; Mian, L.; Konzman, D.; Guo, J.; Yildirimli, D.; Bryant, J.; Fischer, R.; et al. Mutations in human homologue of chicken talpid3 gene (KIAA0586) cause a hybrid ciliopathy with overlapping features of Jeune and Joubert syndromes. J. Med. Genet. 2015, 52, 830–839. [Google Scholar] [CrossRef] [PubMed]
  6. Fraser, A.M.; Davey, M.G. TALPID3 in Joubert syndrome and related ciliopathy disorders. Curr. Opin. Genet. Dev. 2019, 56, 41–48. [Google Scholar] [CrossRef] [PubMed]
  7. Lam, W.Y.; Tang, C.S.; So, M.T.; Yue, H.; Hsu, J.S.; Chung, P.H.; Nicholls, J.M.; Yeung, F.; Lee, C.D.; Ngo, D.N.; et al. Identification of a wide spectrum of ciliary gene mutations in nonsyndromic biliary atresia patients implicates ciliary dysfunction as a novel disease mechanism. EBioMedicine 2021, 71, 103530. [Google Scholar] [CrossRef] [PubMed]
  8. Bachmann-Gagescu, R.; Phelps, I.G.; Dempsey, J.C.; Sharma, V.A.; Ishak, G.E.; Boyle, E.A.; Wilson, M.; Marques, L.C.; Arslan, M.; University of Washington Center for Mendelian Genomics; et al. KIAA0586 is Mutated in Joubert Syndrome. Hum. Mutat. 2015, 36, 831–835. [Google Scholar] [CrossRef] [PubMed]
  9. Ben, J.; Elworthy, S.; Ng, A.S.; van Eeden, F.; Ingham, P.W. Targeted mutation of the talpid3 gene in zebrafish reveals its conserved requirement for ciliogenesis and Hedgehog signaling across the vertebrates. Development 2011, 138, 4969–4978. [Google Scholar] [CrossRef]
  10. Bangs, F.; Antonio, N.; Thongnuek, P.; Welten, M.; Davey, M.G.; Briscoe, J.; Tickle, C. Generation of mice with functional inactivation of talpid3, a gene first identified in chicken. Development 2011, 138, 3261–3272. [Google Scholar] [CrossRef]
  11. Davey, M.G.; Paton, I.R.; Yin, Y.; Schmidt, M.; Bangs, F.K.; Morrice, D.R.; Smith, T.G.; Buxton, P.; Stamataki, D.; Tanaka, M.; et al. The chicken talpid3 gene encodes a novel protein essential for Hedgehog signaling. Genes Dev. 2006, 20, 1365–1377. [Google Scholar] [CrossRef]
  12. Yin, Y.; Bangs, F.; Paton, I.R.; Prescott, A.; James, J.; Davey, M.G.; Whitley, P.; Genikhovich, G.; Technau, U.; Burt, D.W.; et al. The Talpid3 gene (KIAA0586) encodes a centrosomal protein that is essential for primary cilia formation. Development 2009, 136, 655–664. [Google Scholar] [CrossRef] [PubMed]
  13. Cocciadiferro, D.; Agolini, E.; Digilio, M.C.; Sinibaldi, L.; Castori, M.; Silvestri, E.; Dotta, A.; Dallapiccola, B.; Novelli, A. The splice c.1815G>A variant in KIAA0586 results in a phenotype bridging short-rib-polydactyly and oral-facial-digital syndrome: A case report and literature review. Medicine 2020, 99, e19169. [Google Scholar] [CrossRef]
  14. Parisi, M.A. The molecular genetics of Joubert syndrome and related ciliopathies: The challenges of genetic and phenotypic heterogeneity. Transl. Sci. Rare Dis. 2019, 4, 25–49. [Google Scholar] [CrossRef]
  15. Salonen, R.; Herva, R.; Norio, R. The hydrolethalus syndrome: Delineation of a “new,” lethal malformation syndrome based on 28 patients. Clin. Genet. 1981, 19, 321–330. [Google Scholar] [CrossRef] [PubMed]
  16. Paetau, A.; Honkala, H.; Salonen, R.; Ignatius, J.; Kestilä, M.; Herva, R. H7ydrolethalus syndrome: Neuropathology of 21 cases confirmed by HYLS1 gene mutation analysis. J. Neuropathol. Exp. Neurol. 2008, 67, 750–762. [Google Scholar] [CrossRef] [PubMed]
  17. Putoux, A.; Thomas, S.; Coene, K.L.; Davis, E.E.; Alanay, Y.; Ogur, G.; Uz, E.; Buzas, D.; Gomes, C.; Patrier, S.; et al. KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes. Nat. Genet. 2011, 43, 601–606. [Google Scholar] [CrossRef]
  18. Mee, L.; Honkala, H.; Kopra, O.; Vesa, J.; Finnilä, S.; Visapää, I.; Sang, T.K.; Jackson, G.R.; Salonen, R.; Kestilä, M.; et al. Hydrolethalus syndrome is caused by a missense mutation in a novel gene HYLS1. Hum. Mol. Genet. 2005, 14, 1475–1488. [Google Scholar] [CrossRef] [PubMed]
  19. Curinha, A.; Huang, Z.; Anglen, T.; Strong, M.A.; Gliech, C.R.; Jewett, C.E.; Friskes, A.; Holland, A.J. Centriole structural integrity defects are a crucial feature of Hydrolethalus Syndrome. bioRxiv 2024. [Google Scholar] [CrossRef]
  20. Dafinger, C.; Liebau, M.C.; Elsayed, S.M.; Hellenbroich, Y.; Boltshauser, E.; Korenke, G.C.; Fabretti, F.; Janecke, A.R.; Ebermann, I.; Nürnberg, G.; et al. Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics. J. Clin. Investig. 2011, 121, 2662–2667. [Google Scholar] [CrossRef]
  21. Aksu Uzunhan, T.; Ertürk, B.; Aydın, K.; Ayaz, A.; Altunoğlu, U.; Yarar, M.H.; Gezdirici, A.; İçağasıoğlu, D.F.; Gökpınar İli, E.; Uyanık, B.; et al. Clinical and genetic spectrum from a prototype of ciliopathy: Joubert syndrome. Clin. Neurol. Neurosurg. 2023, 224, 107560. [Google Scholar] [CrossRef]
  22. Parisi, M.; Glass, I. Joubert syndrome and related disorders. In GeneReviews; Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Stephens, K., Amemiya, A., Eds.; University of Washington: Seattle, WA, USA, 1993. [Google Scholar]
  23. Joubert, M.; Eisenring, J.J.; Andermann, F. Familial dysgenesis of the vermis: A syndrome of hyperventilation, abnormal eye movements and retardation. Neurology 1968, 18, 302–303. [Google Scholar] [PubMed]
  24. Vilboux, T.; Doherty, D.A.; Glass, I.A.; Parisi, M.A.; Phelps, I.G.; Cullinane, A.R.; Zein, W.; Brooks, B.P.; Heller, T.; Soldatos, A.; et al. Molecular genetic findings and clinical correlations in 100 patients with Joubert syndrome and related disorders prospectively evaluated at a single center. Genet. Med. 2017, 19, 875–882. [Google Scholar] [CrossRef] [PubMed]
  25. Stephen, L.A.; Tawamie, H.; Davis, G.M.; Tebbe, L.; Nürnberg, P.; Nürnberg, G.; Thiele, H.; Thoenes, M.; Boltshauser, E.; Uebe, S.; et al. TALPID3 controls centrosome and cell polarity and the human ortholog KIAA0586 is mutated in Joubert syndrome (JBTS23). eLife 2015, 4, e08077. [Google Scholar] [CrossRef]
  26. Huber, C.; Cormier-Daire, V. Ciliary disorder of the skeleton. Am. J. Med. Genet. 2012, 160C, 165–174. [Google Scholar] [CrossRef] [PubMed]
  27. Schmidts, M.; Vodopiutz, J.; Christou-Savina, S.; Cortes, C.R.; McInerney-Leo, A.M.; Emes, R.D.; Arts, H.H.; Tuysuz, B.; D’Silva, J.; Leo, P.J.; et al. Mutations in the gene encoding IFT dynein complex component WDR34 cause Jeune asphyxiating thoracic dystrophy. Am. J. Hum. Genet. 2013, 93, 932–944. [Google Scholar] [CrossRef]
  28. Girirajan, S.; Eichler, E.E. Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet. 2010, 19, R176–R187. [Google Scholar] [CrossRef]
  29. Reiter, J.F.; Leroux, M.R. Genes and molecular pathways underpinning ciliopathies. Nat. Rev. Mol. Cell Biol. 2017, 18, 533–547. [Google Scholar] [CrossRef]
  30. Kurolap, A.; Mory, A.; Simchoni, S.; Krajden Haratz, K.; Malinger, G.; Birnbaum, R.; Baris Feldman, H.; Yaron, Y. Upgrading an intronic TMEM67 variant of unknown significance to likely pathogenic through RNA studies and community data sharing. Prenat. Diagn. 2022, 42, 1484–1487. [Google Scholar] [CrossRef]
  31. Hiraide, T.; Shimizu, K.; Okumura, Y.; Miyamoto, S.; Nakashima, M.; Ogata, T.; Saitsu, H. A deep intronic TCTN2 variant activating a cryptic exon predicted by SpliceRover in a patient with Joubert syndrome. J. Hum. Genet. 2023, 68, 499–505. [Google Scholar] [CrossRef]
  32. Marshall, A.E.; Lemire, G.; Liang, Y.; Davila, J.; Couse, M.; Care4Rare Canada Consortium; Boycott, K.M.; Kernohan, K.D. RNA sequencing reveals deep intronic CEP120 variant: A report of the diagnostic odyssey for two siblings with Joubert syndrome type 31. Am. J. Med. Genet. A 2024, 194, e63485. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Venn diagram showing described overlapping clinical phenotypes between ciliopathies, as well as single syndrome features. Features written in red correspond to the ones found in our patient. AR: autosomal recessive.
Figure 1. Venn diagram showing described overlapping clinical phenotypes between ciliopathies, as well as single syndrome features. Features written in red correspond to the ones found in our patient. AR: autosomal recessive.
Ijms 25 07900 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Deconte, D.; Diniz, B.L.; Hartmann, J.K.; de Souza, M.A.; Zottis, L.F.F.; Zen, P.R.G.; Rosa, R.F.M.; Fiegenbaum, M. Expanding the Phenotypic Spectrum of Pathogenic KIAA0586 Variants: From Joubert Syndrome to Hydrolethalus Syndrome. Int. J. Mol. Sci. 2024, 25, 7900. https://doi.org/10.3390/ijms25147900

AMA Style

Deconte D, Diniz BL, Hartmann JK, de Souza MA, Zottis LFF, Zen PRG, Rosa RFM, Fiegenbaum M. Expanding the Phenotypic Spectrum of Pathogenic KIAA0586 Variants: From Joubert Syndrome to Hydrolethalus Syndrome. International Journal of Molecular Sciences. 2024; 25(14):7900. https://doi.org/10.3390/ijms25147900

Chicago/Turabian Style

Deconte, Desirée, Bruna Lixinski Diniz, Jéssica K. Hartmann, Mateus A. de Souza, Laira F. F. Zottis, Paulo Ricardo Gazzola Zen, Rafael F. M. Rosa, and Marilu Fiegenbaum. 2024. "Expanding the Phenotypic Spectrum of Pathogenic KIAA0586 Variants: From Joubert Syndrome to Hydrolethalus Syndrome" International Journal of Molecular Sciences 25, no. 14: 7900. https://doi.org/10.3390/ijms25147900

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop